Kikelj D - Search Results

1

An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors.

Tiz DB, Skok Ž, Durcik M, Tomašič T, Mašič LP, Ilaš J, Zega A, Draskovits G, Révész T, Nyerges Á, Pál C, Cruz CD, Tammela P, Žigon D, Kikelj D, Zidar N. Tiz DB, et al. Among authors: kikelj d. Eur J Med Chem. 2019 Apr 1;167:269-290. doi: 10.1016/j.ejmech.2019.02.004. Epub 2019 Feb 10. Eur J Med Chem. 2019. PMID: 30776691

2

Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization.

Zega A, Mlinsek G, Sepic P, Golic Grdadolnik S, Solmajer T, Tschopp TB, Steiner B, Kikelj D, Urleb U. Zega A, et al. Among authors: kikelj d. Bioorg Med Chem. 2001 Oct;9(10):2745-56. doi: 10.1016/s0968-0896(01)00202-4. Bioorg Med Chem. 2001. PMID: 11557360

3

Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.

Marinko P, Krbavcic A, Mlinsek G, Solmajer T, Bakija AT, Stegnar M, Stojan J, Kikelj D. Marinko P, et al. Among authors: kikelj d. Eur J Med Chem. 2004 Mar;39(3):257-65. doi: 10.1016/j.ejmech.2003.12.006. Eur J Med Chem. 2004. PMID: 15051174

4

Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.

Kranjc A, Peterlin-Masic L, Ilas J, Prezelj A, Stegnar M, Kikelj D. Kranjc A, et al. Among authors: kikelj d. Bioorg Med Chem Lett. 2004 Jun 21;14(12):3251-6. doi: 10.1016/j.bmcl.2004.03.085. Bioorg Med Chem Lett. 2004. PMID: 15149685

5

Dual inhibitors of the blood coagulation enzymes.

Kranjc A, Kikelj D. Kranjc A, et al. Among authors: kikelj d. Curr Med Chem. 2004 Oct;11(19):2535-47. doi: 10.2174/0929867043364432. Curr Med Chem. 2004. PMID: 15544461 Review.

6

Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities.

Stefanic Anderluh P, Anderluh M, Ilas J, Mravljak J, Sollner Dolenc M, Stegnar M, Kikelj D. Stefanic Anderluh P, et al. Among authors: kikelj d. J Med Chem. 2005 May 5;48(9):3110-3. doi: 10.1021/jm048984g. J Med Chem. 2005. PMID: 15857114

7

Novel pyrazinone and pyridinone thrombin inhibitors incorporating weakly basic heterobicyclic P(1)-arginine mimetics.

Kranjc A, Masic LP, Reven S, Mikic K, Prezelj A, Stegnar M, Kikelj D. Kranjc A, et al. Among authors: kikelj d. Eur J Med Chem. 2005 Aug;40(8):782-91. doi: 10.1016/j.ejmech.2005.03.007. Eur J Med Chem. 2005. PMID: 15890436

8

The synthesis of alternative diketopiperazines as potential RGD mimetics.

Mihala N, Csámpai A, Ilas J, Kikelj D, Kiss R, Süli-Vargha H. Mihala N, et al. Among authors: kikelj d. J Pept Sci. 2006 Oct;12(10):663-9. doi: 10.1002/psc.776. J Pept Sci. 2006. PMID: 16835887

9

Design, synthesis, biochemical evaluation and antimycobacterial action of phosphonate inhibitors of antigen 85C, a crucial enzyme involved in biosynthesis of the mycobacterial cell wall.

Gobec S, Plantan I, Mravljak J, Svajger U, Wilson RA, Besra GS, Soares SL, Appelberg R, Kikelj D. Gobec S, et al. Among authors: kikelj d. Eur J Med Chem. 2007 Jan;42(1):54-63. doi: 10.1016/j.ejmech.2006.08.007. Epub 2006 Sep 28. Eur J Med Chem. 2007. PMID: 17010479

10

Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.

Ilas J, Hudecz F, Süli-Vargha H, Kikelj D. Ilas J, et al. Among authors: kikelj d. J Pept Sci. 2008 Aug;14(8):946-53. doi: 10.1002/psc.1030. J Pept Sci. 2008. PMID: 18383437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters